search
Back to results

Negative Pressure Wound Therapy to Prevent Wound Complications Following Cesarean Section in High Risk Patients

Primary Purpose

High Risk Pregnancy, Cesarean Wound Disruption With Postnatal Complication

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
PICO Single Use Negative Pressure Wound Therapy
Sponsored by
University of Arizona
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for High Risk Pregnancy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  1. Maternal Age 18 or above
  2. Cesarean delivery
  3. Maternal condition which increases the risk of wound complication. These conditions include: Obesity (BMI >30), diabetes, HIV/AIDS, chorioamnionitis, rheumatologic disease, history of wound complication, anticoagulant therapy.
  4. Patient able to read and speak English or Spanish.

Exclusion Criteria:

  1. Minors (<18 years of age)
  2. Non-cesarean wound (ie tubal ligation wound)
  3. No high risk maternal condition
  4. Patient unable to read and speak English or Spanish.
  5. Prisoners

Sites / Locations

  • Banner University Medical Center Tucson

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Standard dressing

PICO dressing

Arm Description

Standard dressing will be applied after C-section.

Device: PICO Single Use Negative Pressure Wound Therapy

Outcomes

Primary Outcome Measures

Wound Complication
Number of study participants with a wound complication including wound breakdown, infection, separation or dehiscence

Secondary Outcome Measures

Full Information

First Posted
March 13, 2017
Last Updated
September 5, 2022
Sponsor
University of Arizona
search

1. Study Identification

Unique Protocol Identification Number
NCT03082664
Brief Title
Negative Pressure Wound Therapy to Prevent Wound Complications Following Cesarean Section in High Risk Patients
Official Title
Topical Negative Pressure Wound Therapy to Prevent Wound Complications Following Cesarean Section in High Risk Obstetric Patients
Study Type
Interventional

2. Study Status

Record Verification Date
September 2022
Overall Recruitment Status
Completed
Study Start Date
June 2015 (Actual)
Primary Completion Date
March 2019 (Actual)
Study Completion Date
December 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Arizona

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
This is a randomized controlled trial. Patients with a condition that increases their risk of a wound complication will be approached for inclusion in the trial. Each participant agreeing to study inclusion will be randomized to either suture alone or to closure of their skin incision with suture and then with prophylactic placement of a wound vac (PICO).
Detailed Description
Once consent has been obtained from patients, an envelope containing the study allocation will be retrieved from the Pyxis. Non-wound vac patients will undergo wound closure with subcutaneous fat closure with Vicryl in all cases that this is practicable (in extremely thin patients, this may not be possible), followed by subcuticular skin closure also using Vicryl. A compression dressing will then be applied. This dressing is usually removed by the clinician the following day. Wound vac (PICO) patients will undergo wound closure with subcutaneous fat closure with Vicryl in all cases that this is practicable (in extremely thin patients, this may not be possible), followed by subcuticular skin closure also using Vicryl. The wound vac system will then be applied over the closed incision. This vac dressing will then be removed on the day of hospital discharge and replaced with a second bandage and the wound vacuum will be re-activated. The patient will remove the bandage and discard on POD#7. This is per the manufacturer's guidelines for length of use. If the patient fails the wound vac therapy- ie the wound separates and requires traditional wound care (packing, wet to dry dressing, etc), then the PICO system is no longer used as part of their care. It would be unrealistic to try to standardize the entire operative approach (closure of the uterus, closure of the fascia) as the different providers working at the hospital may choose not to participate if the approach specified deviated too much from their usual technique. Different providers may typically use different kinds or sutures (made of different material, and of different sizes) or staples to close the subcutaneous fat and the skin. However, for this study all patients will have the subcutaneous fat and skin closed in the same manner (with Vicryl suture). To participate in the trial patients will have to agree to these closure materials. For this study a standard closure with suture was chosen as there is evidence suggesting a lower rate of wound complications with suture as compared to staples. The wound will be re-assessed at their 2 week and 6 week post-op follow up visits. The patients will be assessed by a physician at their post-operative clinic visits. The physician/investigator will ask the patient if they have had any postoperative complications since their surgery and will be asked to detail any complications if they answer yes to this question. The investigators will also obtain permission to call the participants for a patient satisfaction questionnaire at 1 week post-op, and possibly 2 and 6 weeks if they have not presented for their post op/partum appointments or the questionnaire could not be obtained at their visit.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
High Risk Pregnancy, Cesarean Wound Disruption With Postnatal Complication

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
154 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Standard dressing
Arm Type
No Intervention
Arm Description
Standard dressing will be applied after C-section.
Arm Title
PICO dressing
Arm Type
Experimental
Arm Description
Device: PICO Single Use Negative Pressure Wound Therapy
Intervention Type
Device
Intervention Name(s)
PICO Single Use Negative Pressure Wound Therapy
Other Intervention Name(s)
Smith & Nephew PICO patch
Intervention Description
The PICO device will be placed over the closed cesarean section incision.
Primary Outcome Measure Information:
Title
Wound Complication
Description
Number of study participants with a wound complication including wound breakdown, infection, separation or dehiscence
Time Frame
post operative day 1-42

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Maternal Age 18 or above Cesarean delivery Maternal condition which increases the risk of wound complication. These conditions include: Obesity (BMI >30), diabetes, HIV/AIDS, chorioamnionitis, rheumatologic disease, history of wound complication, anticoagulant therapy. Patient able to read and speak English or Spanish. Exclusion Criteria: Minors (<18 years of age) Non-cesarean wound (ie tubal ligation wound) No high risk maternal condition Patient unable to read and speak English or Spanish. Prisoners
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Meghan Hill, MBBS
Organizational Affiliation
University of Arizona
Official's Role
Principal Investigator
Facility Information:
Facility Name
Banner University Medical Center Tucson
City
Tucson
State/Province
Arizona
ZIP/Postal Code
85724
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Negative Pressure Wound Therapy to Prevent Wound Complications Following Cesarean Section in High Risk Patients

We'll reach out to this number within 24 hrs